Motivations of Patients With Pulmonary Arterial Hypertension to Participate in Randomized Clinical Trials

Clinical Trials- United Kingdom

doi 10.1177/1740774512438981

Full Text

Abstract

Available in

Categories

Date

March 2, 2012

Authors

Darren Taichman

Harold Palevsky

Scott D Halpern

Publisher

SAGE Publications

Related search

Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension

English

Why Community Physicians Should Encourage Their Patients to Participate in Randomized Clinical Trials

Cardiovascular Medicine

English

Pulmonary Arterial Hypertension in Patients Treated With Interferon

European Respiratory Journal

Respiratory Medicine

English

Platelet Indices in Patients With Pulmonary Arterial Hypertension

Clinical and Applied Thrombosis/Hemostasis

English

Single Arterial Occlusion to Locate Resistance in Patients With Pulmonary Hypertension

European Respiratory Journal

Respiratory Medicine

English

Pulmonary Arterial Hypertension in Patients With Primary Sjögren’s Syndrome

Autoimmune Diseases

English

Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension

Therapeutic Advances in Chronic Disease

English

Reasons for Accepting or Declining to Participate in Randomized Clinical Trials for Cancer Therapy

British Journal of Cancer

Cancer Research

English

DOs Encouraged to Participate in Pharmaceutical, Clinical Trials

Journal of the American Osteopathic Association, The

Alternative Medicine

English